HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alan V Boddy Selected Research

Infections

1/2017Pharmacogenetic association of MBL2 and CD95 polymorphisms with grade 3 infection following adjuvant therapy for breast cancer with doxorubicin and cyclophosphamide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alan V Boddy Research Topics

Disease

27Neoplasms (Cancer)
10/2022 - 05/2003
7Breast Neoplasms (Breast Cancer)
01/2017 - 06/2009
5Neuroblastoma
01/2013 - 01/2002
4Melanoma (Melanoma, Malignant)
01/2019 - 05/2005
4Body Weight (Weight, Body)
01/2017 - 10/2004
3Ovarian Neoplasms (Ovarian Cancer)
01/2012 - 03/2007
2Cardiotoxicity
01/2021 - 12/2016
2Non-Hodgkin Lymphoma (Lymphosarcoma)
03/2016 - 01/2004
2Rhabdomyosarcoma
01/2008 - 10/2003
2Neutropenia
11/2007 - 11/2005
1COVID-19
10/2022
1Lymphoma (Lymphomas)
01/2021
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
01/2020
1Fever (Fevers)
01/2019
1Colorectal Neoplasms (Colorectal Cancer)
09/2017
1Infections
01/2017
1Hepatocellular Carcinoma (Hepatoma)
01/2016
1Brain Neoplasms (Brain Tumor)
12/2015
1Glioblastoma (Glioblastoma Multiforme)
12/2015
1Lung Neoplasms (Lung Cancer)
08/2015
1Retinoblastoma (Glioblastoma, Retinal)
09/2012
1Leukemia
10/2011
1Wilms Tumor (Wilm's Tumor)
01/2008
1Disease Progression
11/2007
1Thrombocytopenia (Thrombopenia)
11/2007
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
07/2007
1Neoplasm Metastasis (Metastasis)
03/2007
1Urinary Bladder Neoplasms (Bladder Cancer)
03/2007
1Sarcoma (Soft Tissue Sarcoma)
09/2006

Drug/Important Bio-Agent (IBA)

7Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 10/2011
6Dactinomycin (Actinomycin)FDA LinkGeneric
12/2018 - 10/2003
6Carboplatin (JM8)FDA LinkGeneric
09/2012 - 08/2002
5Cyclophosphamide (Cytoxan)FDA LinkGeneric
01/2017 - 01/2004
4DNA (Deoxyribonucleic Acid)IBA
03/2016 - 02/2009
3AnthracyclinesIBA
01/2021 - 12/2011
3Temozolomide (Temodar)FDA LinkGeneric
12/2015 - 05/2005
2Interleukin-6 (Interleukin 6)IBA
10/2022 - 01/2019
2Imatinib Mesylate (Gleevec)FDA Link
10/2022 - 07/2007
2Biomarkers (Surrogate Marker)IBA
01/2021 - 01/2016
2Drug CombinationsIBA
01/2020 - 08/2002
2dabrafenibIBA
01/2019 - 01/2017
2Monoclonal AntibodiesIBA
01/2019 - 06/2009
2trametinibIBA
01/2019 - 01/2017
21- cyclopropyl- 3- (3- (5- morpholin- 4- ylmethyl- 1H- benzoimidazol- 2- yl)- 1H- pyrazol- 4- yl)ureaIBA
01/2017 - 01/2015
2Aromatase InhibitorsIBA
11/2016 - 08/2016
2Poly(ADP-ribose) Polymerase InhibitorsIBA
12/2015 - 02/2009
2rucaparibIBA
12/2015 - 02/2009
2Isotretinoin (Accutane)FDA LinkGeneric
01/2013 - 07/2010
2NRH - quinone oxidoreductase2IBA
12/2011 - 03/2007
2Tretinoin (Retinoic Acid)FDA LinkGeneric
07/2010 - 01/2002
2Etoposide (VP 16)FDA LinkGeneric
05/2010 - 09/2006
2Poly (ADP-Ribose) Polymerase-1IBA
02/2009 - 05/2005
2Paclitaxel (Taxol)FDA LinkGeneric
11/2007 - 11/2005
1Glycoproteins (Glycoprotein)IBA
10/2022
1Dexamethasone (Maxidex)FDA LinkGeneric
10/2022
1AcidsIBA
10/2022
1Clofarabine (Clolar)FDA Link
01/2020
1Mitogen-Activated Protein Kinase Kinases (MEKs)IBA
01/2019
1CytokinesIBA
01/2019
1CurcuminIBA
09/2017
1TroponinIBA
12/2016
1Natriuretic PeptidesIBA
12/2016
1Vitamin A (Retinol)FDA LinkGeneric
10/2016
1retinol acetateIBA
10/2016
1Carotenoids (Carotene)IBA
10/2016
1Estrogen ReceptorsIBA
08/2016
1Indicators and Reagents (Reagents)IBA
03/2016
1human ERBB2 proteinIBA
03/2016
1ErbB Receptors (EGF Receptor)IBA
03/2016
1SilkFDA Link
08/2015
1Drug CarriersIBA
08/2015
1Aurora Kinase AIBA
01/2015
1Aurora KinasesIBA
01/2015
1Epirubicin (Ellence)FDA LinkGeneric
10/2014
1Fluorouracil (Carac)FDA LinkGeneric
10/2014
1Alkylating AgentsIBA
10/2014
1carboplatin-DNA adductIBA
01/2012
1TamoxifenFDA LinkGeneric
12/2011
1Trastuzumab (Herceptin)FDA Link
06/2009
1Oncogene Proteins (Oncogene Protein)IBA
06/2009
1Antisense OligonucleotidesIBA
05/2009
1MethyltransferasesIBA
05/2009
1Topotecan (Hycamtin)FDA LinkGeneric
02/2009
1ixabepilone (BMS 247550)FDA Link
12/2008
1Messenger RNA (mRNA)IBA
03/2007
1NAD (NADH)IBA
03/2007
1Oxidoreductases (Dehydrogenase)IBA
03/2007
1quinone (benzoquinone)IBA
03/2007
1tretazicarIBA
03/2007
1Anti-Bacterial Agents (Antibiotics)IBA
08/2005
1Alkyl and Aryl TransferasesIBA
05/2005
1Proteins (Proteins, Gene)FDA Link
05/2005

Therapy/Procedure

10Therapeutics
01/2021 - 03/2007
4Drug Therapy (Chemotherapy)
01/2021 - 01/2004
3Oral Administration
10/2016 - 05/2003
1Duration of Therapy
01/2021
1Immunotherapy
01/2019
1Precision Medicine
11/2016
1Lasers (Laser)
12/2015
1Cytoreduction Surgical Procedures
11/2007